Smiths Medical 21-4008-24 - PORT INFUSION SINGLE LUMEN TITANIUM DETACHED SILICONE CATHETER 9FR INTRODUCER

Smiths Medical 21-4008-24 - PORT INFUSION SINGLE LUMEN TITANIUM DETACHED SILICONE CATHETER 9FR INTRODUCER

The Smiths Medical 21-4008-24 Port Infusion System is a single lumen implantable port designed for reliable long-term vascular access. Constructed with a durable titanium housing and paired with a flexible detached silicone catheter, this system provides consistent performance in demanding clinical environments. The included 9Fr introducer supports efficient placement, making it suitable for a wide range of infusion therapies including chemotherapy, parenteral nutrition, and long-term medication delivery.

Key Benefits

This infusion port system offers exceptional durability through its titanium construction, ensuring long-term structural integrity within the body. The single lumen design simplifies management while maintaining reliable access for repeated infusions. The detached silicone catheter enhances flexibility and patient comfort while reducing vessel irritation. Its compatibility with standard non-coring needles supports safe and repeated access without compromising the septum.

Compatibility and Applications

The system is compatible with standard infusion protocols and is widely used in oncology, chronic disease management, and long-term intravenous therapies. It is suitable for use with non-coring Huber needles and integrates seamlessly with common infusion pumps and delivery systems. The 9Fr introducer ensures compatibility with standard insertion techniques used by trained clinicians.

Usage Guidelines

The port should be implanted by a qualified healthcare professional following established sterile surgical procedures. Proper positioning of the catheter tip must be confirmed using imaging techniques. Access should only be performed using appropriate non-coring needles to preserve septum integrity. Regular flushing protocols must be followed to maintain patency and reduce the risk of occlusion.

Certifications and Safety Standards

This product is manufactured in accordance with strict medical device quality standards and complies with applicable regulatory requirements. The materials used are biocompatible and designed to meet safety expectations for long-term implantation. Each unit undergoes quality assurance processes to ensure consistent performance and patient safety.

Comparison with Competitors

Compared to alternative infusion port systems, this model stands out due to its robust titanium construction combined with a highly flexible silicone catheter. While some systems use composite or plastic ports, titanium offers superior longevity and resistance to wear. The detached catheter design also provides greater adaptability during placement compared to fixed systems, giving clinicians more control during implantation.

Typical User Profile and Application Scenarios

This product is commonly used by oncologists, interventional radiologists, and surgical teams managing patients requiring repeated vascular access. It is ideal for patients undergoing chemotherapy, long-term antibiotic therapy, or total parenteral nutrition. Hospitals, outpatient infusion centers, and specialty clinics rely on this system for dependable performance in both routine and complex cases.

Best Practices for Use and Maintenance

To ensure optimal performance, clinicians should follow strict aseptic techniques during access and maintenance. Routine flushing with appropriate solutions should be carried out as per institutional guidelines. Regular inspection of the port site is recommended to detect early signs of infection or complications. Proper training of staff handling the device is essential to maintain safety and functionality.

Regulatory and Safety Information

This device is intended for use by trained healthcare professionals only. It should be used in accordance with all applicable clinical guidelines and institutional protocols. Patients should be monitored for potential complications such as infection, thrombosis, or catheter occlusion. Any adverse events should be reported in line with regulatory requirements.

How to Order

To place an order or to get more information about this product, please contact CIA Medicals customer care team at (312) 275-5850. Our team is available to assist with product details, availability, and bulk purchasing options.